Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

Apollo Hospitals - No.1 Indian Heart Hospital as per latest Newsweek survey

Posted On: 2021-09-28 22:29:38 (Time Zone: IST)

Apollo Hospitals today announced the national launch of an AI (artificial intelligence) tool to predict risk of cardiovascular disease. The Apollo AI-powered Cardiovascular Disease Risk tool will help healthcare providers to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference. The cardiac risk scoring tool is remarkable for the speed in processing data and its accuracy at predicting the probability of a patient developing coronary disease. Using the tool, physicians will be enabled to deliver proactive, pre-emptive and preventive care for at-risk individuals, improving lives while mitigating future pressure on healthcare systems.

On the occasion, Apollo Hospitals also announced that it has found pride of place in the Best Specialized Hospitals 2022 ranking released by Newsweek, the premier international news magazine and website. The ranking in partnership with global research firm Statista ranks the world's best specialized hospitals and features the top 250 hospitals for cardiology and oncology and the top 150 for paediatrics among ten specialities. The Apollo Heart Centre at Apollo Hospitals, Chennai makes it to the list of Best Specialized Hospitals 2022 - Cardiology with a global rank of 126 and ranks No. 1 among the five Indian hospitals in the list.

Also, in the Best Specialized Hospitals 2022 - Oncology, two hospitals from the Apollo Hospitals Group make it to the list with Apollo Cancer Centres at Apollo Speciality Cancer Hospital, Chennai and Apollo Hospitals, Chennai ranked at 228 and 239 respectively. The two hospitals are among just four Indian hospitals that are in list for Oncology. In the Paediatric speciality, Apollo Children's Hospital, Chennai ranked at 103 globally and one among just five Indian hospitals that are part of the Best Specialized Hospitals 2022 - Paediatrics ranking.

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, "The nation's economy is intricately linked to the health of the people with non-communicable diseases (NCDs) leading to loss of productivity with a consequent impact on national income.

While estimates suggest that NCDs account for an economic burden in the range of 5% to 10% of GDP, it is the chronic nature of NCDs, and their projected increase in prevalence, that will result in a growing economic impact if not addressed in time. Among the rising burden of NCDs, cardiovascular diseases (CVDs) figure at the top. Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as our populations continue to age. It's also a problem that healthcare providers struggle to diagnose early enough to make a real difference.

"While some predictive tools do exist to help physicians understand the probability of their patients developing heart disease, most of these are based on Western data sets and don't take regional risk variations into account. This impacts their accuracy when applied in an Indian context. The Apollo AI-powered Cardiovascular Disease Risk tool will change that and put the knowledge and the means to predict and prevent heart disease in the physician's hands. Available till now only to Apollo's physicians, it is a proud moment for us to dedicate this AI tool to all physicians in the country."

Speaking on the Newsweek recognition, Dr. Prathap C Reddy added, "This global recognition is testament to the specialty healthcare of international standards provided at Apollo Hospitals with outcomes matching those of the world's best hospitals. Apollo Hospitals, with some of the world's finest and brightest medical experts, has been the pioneer in bringing ground-breaking healthcare technologies to India to deliver best in class clinical results."

The team at Apollo Hospitals collected more than ten years of data relating to 400,000 individuals across the country. Then, they used Microsoft Azure to turn that anonymized data into actionable insights that data scientists and clinicians could use to train machine learning models. The tool has been validated using data from the Maastricht Study, a long-term cohort health study in the Maastricht region and from the Heart+Vascular Center at Maastricht University Medical Center, Netherlands.

Ms. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, "The AI tool to predict and prevent heart disease is the fruition of many years of research and development and stands testament to Apollo Hospitals' technological prowess. Apollo's AI-powered Cardiovascular Disease Risk Score is specifically for use in the Indian population, so physicians can better predict the risk of cardiac disease in their patients. The tool is built on algorithms based on ten years of anonymized data relating to around 400,000 individuals across the country collected by the team at Apollo Hospitals.

"The tool has also been validated internationally using federated learning through Microsoft Azure Platform. Doctors across the Apollo network have been leveraging this AI-powered tool for three years to predict risk of cardiovascular disease and drive preventive cardiac care across the country. With this launch of the AI tool to predict risk of heart disease, we will be able to help achieve the World Health Organization's goal of reducing the risk of premature mortality from non-communicable diseases, including CVDs, by 25% by 2025."

The AI-powered tool delivers a more accurate CVD risk score using algorithms specifically for the Indian population and helps in developing standardised care regimens. Developed using a combination of applied AI and clinical expertise on a large sample of retrospective data on health checks and coronary events, the tool delivers a risk score that takes into account all contributing factors including lifestyle attributes such as diet, tobacco & smoking preferences and physical activity as well as psychological stress and anxiety as reflected via rate of respiration, and hypertension. The risk is categorized into High, Moderate and Minimal. The tool also gives insights on the risk contributors that can be modified to improve the score. This enables physicians to give a more holistic advice to their patients with specific insights for lifestyle modification.

Shares of Apollo Hospitals Enterprises Ltd., was last trading in BSE at Rs. 4411.75 as compared to the previous close of Rs. 4565.75. The total number of shares traded during the day was 148023 in over 9022 trades.

The stock hit an intraday high of Rs. 4644 and intraday low of 4376.4. The net turnover during the day was Rs. 659945858.

Click here to send ur comments or to

Other Headlines:

HCL Technologies Launches HCL SMARTWiFi Platform for Communication Service Providers

Lupin sinks to Q2FY22 consolidated loss of Rs. 2098.04 crores

Larsen & Toubro announces earnings for Q2FY22, H1FY22

Cigniti Recognized as Market Leader in Continuous Testing Specialists for the US by ISG

Sharika Enterprises Ltd receives order worth Rs. 12.33 crore

Now IRCTC 139 Calls are Truecaller Verified

KIMS Hospitals to acquire 51.07% stake in Sunshine Hospitals

Karnataka Bank awarded at the 19th edition of Asia Pacific HRM Congress

Cummins India Limited announces results for Q2 2021-22

Monte Cello BV to Divest Mt Lyell Copper Mine in Australia

Vaibhav Global Ltd reports Rs. 42.18 crore consolidated PAT in Q2 FY22

Happiest Minds Technologies Ltd Q2FY22 consolidated net profit higher at Rs. 44.44 crore

Oracle Financial Services Software Ltd Q2FY22 consolidated net profit at Rs. 447.55 crore

Shriram City Union Finance Ltd reports consolidated PAT of Rs. 298.47 crores in Q2 FY2021-22

ITC Ltd Q2FY22 consolidated PAT rises QoQ, YoY to Rs. 3713.76 crore

MPS Ltd consolidated Q2 FY2021-22 net profit up at Rs. 21.66 crore

KEC International Ltd consolidated Q2FY22 PAT at Rs. 80.29 crore

PNB consolidated Q2FY22 PAT falls QoQ to Rs. 1104.25 crore

Aegis Logistics Ltd consolidated Q2FY22 PAT jumps to Rs. 94.40 crore

MAS Financial Services Ltd Q2FY22 consolidated net profit at Rs. 39.12 crore

Timex Group India Ltd Q2FY22 net profit at Rs. 11.35 crore

Cummins India Ltd Q2FY22 consolidated PAT at Rs. 221.03 crore

Triveni Engineering and Industries Ltd posts consolidated PAT of Rs. 92.47 crore in Q2 FY22

Prerna Infrabuild Ltd Q2FY22 consolidated PAT at Rs. 1.43 crore

Deepak Nitrite Ltd Q2FY22 net profit drops QoQ to Rs. 254.34 crores

IIFL Wealth Management Ltd reports Rs. 142.48 crore consolidated PAT in Q2FY22

HIL Ltd consolidated Q2FY22 PAT declines to Rs. 26.11 crore

Sagar Cements Ltd Q2FY22 consolidated net profit falls to Rs. 21.07 crore

SIS Ltd reports consolidated PAT of Rs. 68.38 crore in Q2FY22

Continental Securities Ltd Q2FY22 net profit up at Rs. 13.44 lakhs

Cosmo Films Ltd reports Rs. 97.30 crores consolidated PAT in Q2 FY2021-22

Ecoboard Industries Ltd posts PAT of Rs. 1.17 crore in Q2 FY2021-22

United Breweries Ltd Q2FY22 consolidated net profit surges to Rs. 80.38 crore

Bajaj Auto Ltd consolidated PAT surges to Rs. 2039.86 crores in Q2FY22

Adani Enterprises Ltd consolidated Q2FY22 net profit slides to Rs. 212.41 crore

Sunil Healthcare Ltd posts consolidated Q2FY22 PAT of Rs. 3.97 lakhs

Dalmia Bharat Ltd reports consolidated net profit of Rs. 204 crore in Q2FY22

IKAB Securities and Investment Ltd Q2FY22 PAT at Rs. 3.05 crore

Share India Securities Ltd Q2FY22 consolidated PAT jumps to Rs. 42.80 crore

Tube Investments of India Ltd posts QoQ, YoY rise in consolidated profit

Balaji Amines Ltd consolidated Q2FY22 PAT slips QoQ to Rs. 79.75 crore

Resonance Specialties Ltd Q2FY22 PAT at Rs. 3.35 crore

KEI Industries Ltd posts consolidated PAT of Rs. 91.70 crore in Q2FY22

Ramco Systems Ltd Q2FY22 consolidated loss at Rs. 12.90 crore

IndusInd Bank Ltd posts consolidated PAT of Rs. 1146.67 crore

Super Sales India Ltd Q2FY22 net profit at Rs. 15.44 crore

Wipro Partners with Micro Focus to Streamline Legacy Apps Migration to Cloud

Triveni Engineering & Industries Ltd Board approves interim dividend of Rs. 1.25

Poonawalla Fincorp Q2FY22 Consolidated Profit Before Tax up 151% YoY to ₹ 126 Cr

Mahindra Logistics Q2 FY22 Revenue at Rs. 1,019 Cr, PAT Rs. 9 Cr

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020